May Kin Ho
Director/Board Member chez PAREXEL INTERNATIONAL CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
May Kin Ho is currently serving as a Director at PAREXEL International Corp., BioMarin Pharmaceutical, Inc., Agios Pharmaceuticals, Inc., FibroGen, Inc., The Aaron Diamond AIDS Research Center, Parexel International Corp.
Ltd., Institute For Protein Innovation, Inc., Neumora Therapeutics, Inc., and as a Venture Partner at Qiming Venture Partners Ltd.
Dr. Ho is also the Managing Partner at Viridian Global Logistics, Inc. In the past, Dr. Ho held positions as an Independent Director at PAREXEL International Corp., GRAIL LLC, and as a Director-Strategic Planning, Marketing & Research at DuPont Merck Pharmaceutical Co. and Dupont De Nemours & Co., Inc. Dr. Ho also worked at The Goldman Sachs Group, Inc. as a Partner & Co-Head-Healthcare and at Goldman Sachs & Co. LLC as a Research Analyst.
Dr. Ho obtained a doctorate degree from the State University of New York at Downstate Medical Center in 1980 and an undergraduate degree from the same institution in 1975.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/05/2023 | 16 640 ( 0,01% ) | 1 M $ | 31/03/2024 | |
| 21/06/2023 | 11 524 ( 0,02% ) | 336 962 $ | 31/03/2024 | |
FIBROGEN, INC.
0,03% | 08/06/2023 | 31 501 ( 0,03% ) | 74 027 $ | 31/03/2024 |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. -.--% | 31/08/2020 | 0 ( -.--% ) | - $ | 31/08/2020 |
| 15/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de May Kin Ho
| Sociétés | Poste | Début |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director/Board Member | 23/06/2015 |
| FIBROGEN, INC. | Director/Board Member | 06/12/2018 |
| BIOMARIN PHARMACEUTICAL INC. | Director/Board Member | 17/02/2021 |
| NEUMORA THERAPEUTICS, INC. | Director/Board Member | 01/04/2021 |
| PAREXEL INTERNATIONAL CORPORATION | Director/Board Member | 01/03/2018 |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Private Equity Investor | - |
Parexel International Corp. Ltd.
 Parexel International Corp. Ltd. Financial ConglomeratesFinance Parexel International Corp. Ltd. functions as an investment holding British company. The private company is based in Basingstoke, UK. | Director/Board Member | 12/03/2018 |
Institute For Protein Innovation, Inc.
 Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Director/Board Member | 01/01/2016 |
The Aaron Diamond AIDS Research Center
 The Aaron Diamond AIDS Research Center Miscellaneous Commercial ServicesCommercial Services The Aaron Diamond AIDS Research Center for the City of New York, Inc. provides research and clinical testing solutions for HIV and AIDS. The firm focuses on basic science of AIDS and its related research. The company was founded by Irene Diamonds on April 16, 1991 and is headquartered in New York, NY. | Director/Board Member | 01/01/2005 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de May Kin Ho
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
Formation de May Kin Ho
| State University of New York at Downstate Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| THE GOLDMAN SACHS GROUP, INC. | Finance |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
Qiming Venture Partners Ltd.
Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Finance |
The Aaron Diamond AIDS Research Center
The Aaron Diamond AIDS Research Center Miscellaneous Commercial ServicesCommercial Services The Aaron Diamond AIDS Research Center for the City of New York, Inc. provides research and clinical testing solutions for HIV and AIDS. The firm focuses on basic science of AIDS and its related research. The company was founded by Irene Diamonds on April 16, 1991 and is headquartered in New York, NY. | Commercial Services |
Dupont De Nemours & Co., Inc.
 Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Part of Corteva, Inc., Dupont De Nemours & Co., Inc. is a private company that manufactures hybrid corn and soybean seeds. The company is based in Wilmington, DE. | Process Industries |
| Viridian Global Logistics, Inc. | |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Technology |
Parexel International Corp. Ltd.
Parexel International Corp. Ltd. Financial ConglomeratesFinance Parexel International Corp. Ltd. functions as an investment holding British company. The private company is based in Basingstoke, UK. | Finance |
Institute For Protein Innovation, Inc.
Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Commercial Services |
